BAYNN Stock Chart & Stats
$779.00
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$430.63 - $1,050.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$900.04B
Enterprise Value$71.97K
Total Cash (Recent Filing)$6.66B
Total Debt (Recent Filing)$38.89B
Price to Earnings (P/E)―
Beta0.32
Next Earnings
Aug 04, 2026EPS Estimate
15.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.19
Shares Outstanding982,424,100
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.40
Price to Sales (P/S)0.80
P/FCF Ratio17.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,100.34Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Positive Operating And Free Cash FlowSustained positive operating and free cash flow provide durable internal funding for R&D, regulatory filings, and crop/pharma product launches. Even with weaker momentum, ~€2B FCF supports debt servicing and strategic investment without relying solely on capital markets.
Strong Underlying Operating MarginsHigh gross and mid-teens operating margins indicate structural profitability in core operations driven by product mix and scale. These margins create a buffer against pricing and regulatory headwinds and support long-term reinvestment into R&D and commercial capabilities.
Diversified Life-sciences Business ModelA two-pronged pharmaceuticals and crop-science model spreads commercial and regulatory risk across health and agriculture cycles. Diversification sustains revenue sources through biotech pipelines, seed/trait sales and crop protection, enabling cross-division resource allocation over multi-year investment horizons.
Bears Say
Multi-year Net Losses And Negative Reported EarningsRecurring reported net losses signal structural headwinds beyond one-time items, eroding retained earnings and limiting shareholder returns. Persistent negative bottom-line results constrain capital allocation choices, increase scrutiny from stakeholders, and raise the bar for operational turnaround.
Declining Revenue TrendSustained revenue decline reduces operating leverage and makes margin maintenance harder over time. Falling top-line trends can reflect competitive pressure, product lifecycle losses or pricing challenges, which undermine the firm's ability to fund R&D and deleveraging without structural commercial fixes.
Levered Balance Sheet And Constrained Deleveraging CapacityA debt-heavy capital structure raises interest and refinancing risk and limits strategic flexibility for M&A or sustained R&D investment. Low coverage of debt by operating cash flow implies slower deleveraging absent higher profits or asset sales, increasing sensitivity to earnings volatility.
BAYNN FAQ
What was Bayer Ag (UK)’s price range in the past 12 months?
Bayer Ag (UK) lowest stock price was $430.63 and its highest was $1050.00 in the past 12 months.
What is Bayer Ag (UK)’s market cap?
Bayer Ag (UK)’s market cap is $900.04B.
When is Bayer Ag (UK)’s upcoming earnings report date?
Bayer Ag (UK)’s upcoming earnings report date is Aug 04, 2026 which is in 10 days.
How were Bayer Ag (UK)’s earnings last quarter?
Bayer Ag (UK) released its earnings results on May 12, 2026. The company reported $54.032 earnings per share for the quarter, beating the consensus estimate of $46.097 by $7.935.
Is Bayer Ag (UK) overvalued?
According to Wall Street analysts Bayer Ag (UK)’s price is currently Undervalued.
Does Bayer Ag (UK) pay dividends?
Bayer Ag (UK) pays a N/A dividend of $2.19 which represents an annual dividend yield of N/A. See more information on Bayer Ag (UK) dividends here
What is Bayer Ag (UK)’s EPS estimate?
Bayer Ag (UK)’s EPS estimate is 15.33.
How many shares outstanding does Bayer Ag (UK) have?
Bayer Ag (UK) has 982,424,100 shares outstanding.
What happened to Bayer Ag (UK)’s price movement after its last earnings report?
Bayer Ag (UK) reported an EPS of $54.032 in its last earnings report, beating expectations of $46.097. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bayer Ag (UK)?
Currently, no hedge funds are holding shares in MX:BAYNN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Bayer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1,100.34 (― Downside)
$1,100.34 (― Downside)
Blogger Sentiment
Bullish
MX:BAYNN Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
70.33%
12-Months-Change
Fundamentals
Return on Equity
0.28%
Trailing 12-Months
Asset Growth
-1.13%
Trailing 12-Months
Company Description
Bayer Ag (UK)
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
BAYNN Stock 12 Month Forecast
Average Price Target
$1,100.34